TPC Drops Ophthalmic Solution Recalled for Lack of Sterility Assurance
Pine Pharmaceuticals is recalling TPC Drops ophthalmic solution due to lack of assurance of sterility. The recall affects 1693 droppers distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II recall of a prescription ophthalmic solution with lack of assurance of sterility, creating a risk of contamination and potential eye infections. No illnesses or injuries have been reported, and the hazard remains theoretical. Per the rubric, a risk-of-harm product with no reported injury scores at most 3 (High).
Plain-English summary
Pine Pharmaceuticals, LLC is recalling TPC Drops ophthalmic solution (containing tropicamide 1%, phenylephrine 2.5%, and cyclopentolate HCl 1%) due to lack of assurance of sterility. The recall involves two lots: Lot #68184 (expiration 10/9/2023) and Lot #68623 (expiration 11/2/2023), totaling 1693 droppers.
The product is a compounded prescription ophthalmic solution distributed nationwide. Without assured sterility, the solution may become contaminated, potentially leading to eye infections or other serious complications when administered.
Consumers who have received this medication should contact their healthcare provider or pharmacist for guidance. Patients should not use this product without consulting their healthcare provider. Healthcare providers and pharmacies should remove affected lots from inventory and advise patients accordingly.
The recalled product
- Product
- TPC Drops (tropicamide 1%- phenylephrine 2.5%- cyclopentolate HCl 1% ophthalmic solution, 5 mL droppers, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
- Manufacturer
- Pine Pharmaceuticals, LLC
- Category
- Drug — Ophthalmic / Eye Drops
- Affected units
- 1,693
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 68184
- Exp. Date 10/9/2023
- 68623
- Exp. Date 11/2/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Pine Pharmaceuticals, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Pine Pharmaceuticals, LLC
See all →- HighVancomycin Intraocular Injection Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-10-25
- HighFDA Recalls Compounded Moxifloxacin Syringes for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighFoscarnet Sodium Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighLidocaine eye drops recalled due to lack of sterility assurance
FDA (Drugs) · 2023-10-25
- HighEndophth Kit Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15